Austin Wang, PhD
Dr. Austin Wang joined Juvena Therapeutics as a Corporate Development Manager. Before joining, Dr. Wang spent 6 months as a Neuroscience Fellow at Mubadala Capital and also conducted several consulting engagements as a part of Biotech Connections Bay Area with biotech and venture capital firms. Dr. Wang comes with experience in clinical trial assessments, asset evaluation, and market/competitive landscape.
Dr. Wang received his PhD in Neuroscience from UCSF in Dr. Aimee Kao’s lab where he studied the cellular molecular properties of neurodegeneration, with an emphasis on protein homeostasis through lysosomal regulation. Prior to UCSF, he spent two years studying the biochemical regulation of neuronal vesicle fusion in Dr. Axel Brunger’s lab at Stanford University. He graduated from UCLA with a B.S. in Physiological Science where he studied neuronal pathways underlying sensory integration in Dr. Mark Frye’s lab. In addition to his first-author publication in Human Molecular Genetics, Dr. Wang has co-authored 9 publications in top-tier journals, including a second author Nature paper.
Dr. Wang is passionate about translating scientific research into commercially successful clinical solutions for patients. At Juvena Therapeutics, he works in a cross functional capacity to support many functions related to corporate development. Outside of work, he enjoys cycling on the weekends and playing strategy board games.
Learn more about Austin